A Study to Evaluate PK, Efficacy, and Safety of BAT3306 Plus Chemo and Compare With Keytruda ®(EU/US) in Participants With IV nqNSCLC

Conditions: Carcinoma, Non-Small-Cell Lung Interventions: Drug: BAT3306; Drug: EU-Keytruda ®; Drug: US-Keytruda®; Drug: Pemetrexed; Drug: Carboplatin Sponsors: Bio-Thera Solutions Not yet recruiting

https://clinicaltrials.gov/study/NCT06280196

Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials